The Scientific and R&D Team at Recursion Pharmaceuticals spearheads the experimental and discovery efforts to identify and develop new drug candidates. Leveraging a multidisciplinary approach that combines experimental biology, chemistry, and artificial intelligence, this team focuses on understanding disease mechanisms, optimizing drug formulations, and advancing promising candidates through preclinical and clinical stages. Their collaborative work aims to accelerate the discovery of effective treatments for various genetic disorders, inflammatory conditions, immunological diseases, and infections.
Aimee Iberg
Director Of Translational Onco...
Carl Brooks
Senior Director Of Chemistry
Chandana Haque
Executive Director of Biotech ...
Christopher Bailey
Associate Principal Scientist ...
Doo-Hyun Kwon
Associate Principal Scientist
Gabriela Andrejeva
Director, Oncology - Industria...
Mark Parnell
Associate Director, Assay Deve...
Mike Genin
VP, Chemistry
Najat Khan
Chief R&D Officer & Chief Comm...
Ron Alfa
SVP, Translational Discovery
Shadi Swaidani
Principal Scientist Immunology...
Sharath Hegde
Chief Scientific Officer
Yolanda Chong
SVP, Biology
Zijian Xiong
Senior Scientist
View all